CACNA1S Gene Thyrotoxic Periodic Paralysis Type 1 Genetic Test sale cost 4400 AED
PRKCG Gene Spinocerebellar Ataxia Type 14 Autosomal Dominant Genetic Test sale cost 4400 AED PRKCG Gene Spinocerebellar Ataxia Type 14 Autosomal Dominant Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
TTPA Gene Vitamin E Familial Deficiency Genetic Test sale cost 4400 AED TTPA Gene Vitamin E Familial Deficiency Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CACNA1S Gene Thyrotoxic Periodic Paralysis Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CACNA1S gene plays a crucial role in the normal functioning of skeletal muscle cells. Mutations in this gene can lead to Thyrotoxic Periodic Paralysis Type 1, a condition characterized by episodes of muscle weakness or paralysis, often triggered by high levels of thyroid hormones. This genetic disorder is linked to an abnormal response of muscle cells to potassium levels in the body, particularly during instances of thyrotoxicosis, where excessive thyroid hormone is present.

To diagnose this condition and differentiate it from other forms of periodic paralysis, genetic testing of the CACNA1S gene is essential. DNA Labs UAE offers a comprehensive genetic test specifically designed to identify mutations in the CACNA1S gene associated with Thyrotoxic Periodic Paralysis Type 1. This test is pivotal for confirming the diagnosis, understanding the risk of passing the condition to offspring, and guiding treatment decisions.

The cost of the CACNA1S Gene Thyrotoxic Periodic Paralysis Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the detailed analysis required to detect the presence of the specific genetic alterations within the CACNA1S gene that cause the disorder. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic basis of the symptoms, enabling personalized management plans that can significantly improve the quality of life for those affected by this condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CACNA1S Gene Thyrotoxic Periodic Paralysis Type 1 Genetic Test

Welcome to DNA Labs UAE, where we offer the CACNA1S Gene Thyrotoxic Periodic Paralysis Type 1 Genetic Test. This test helps diagnose and identify mutations in the CACNA1S gene, which is responsible for encoding the alpha-1S subunit of the L-type voltage-dependent calcium channel.

Test Details

The CACNA1S gene plays a crucial role in the development of thyrotoxic periodic paralysis type 1 (TPP1). TPP1 is a rare genetic disorder characterized by episodes of muscle weakness or paralysis triggered by high levels of thyroid hormones in the blood. These episodes primarily affect the muscles of the arms and legs and can last from a few hours to several days.

Our genetic test utilizes Next-Generation Sequencing (NGS) technology to analyze multiple genes simultaneously and identify any mutations or variations in their DNA sequences. By specifically focusing on the CACNA1S gene, we can detect mutations that may be responsible for TPP1.

Test Components and Price

The CACNA1S Gene Thyrotoxic Periodic Paralysis Type 1 Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

After the sample is collected, the report will be delivered within 3 to 4 weeks. Our team of neurologists in the Genetics Department will thoroughly analyze the results to provide an accurate diagnosis.

Pre-Test Information

Before undergoing the CACNA1S Gene Thyrotoxic Periodic Paralysis Type 1 Genetic Test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by TPP1. This information helps in understanding the inheritance pattern and identifying potential carriers.

Benefits of the Test

By identifying mutations in the CACNA1S gene, healthcare professionals can provide a more accurate diagnosis, predict the likelihood of developing TPP1, and offer appropriate treatment options and genetic counseling to affected individuals and their families. Early detection and intervention can significantly improve the quality of life for those affected by TPP1.

At DNA Labs UAE, we prioritize providing reliable and accurate genetic testing services. Our NGS technology allows us to analyze multiple genes simultaneously, providing comprehensive results. If you suspect that you or your family member may have TPP1, don’t hesitate to consult with our neurologists and genetic specialists for guidance and support.

Test Name CACNA1S Gene Thyrotoxic periodic paralysis type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CACNA1S Gene Thyrotoxic periodic paralysis type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1S Gene Thyrotoxic periodic paralysis type 1
Test Details

The CACNA1S gene is responsible for encoding a protein called the alpha-1S subunit of the L-type voltage-dependent calcium channel. Mutations in this gene can lead to a condition called thyrotoxic periodic paralysis type 1 (TPP1).

Thyrotoxic periodic paralysis is a rare genetic disorder characterized by episodes of muscle weakness or paralysis that are typically triggered by high levels of thyroid hormones in the blood (thyrotoxicosis). These episodes usually affect the muscles of the arms and legs and can last from a few hours to several days.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify any mutations or variations in their DNA sequences. In the case of thyrotoxic periodic paralysis type 1, NGS genetic testing can be used to detect mutations in the CACNA1S gene that may be responsible for the condition.

By identifying these mutations, healthcare professionals can provide a more accurate diagnosis, predict the likelihood of developing TPP1, and offer appropriate treatment options and genetic counseling to affected individuals and their families.

SKU: TEST-2089 Category:

Related products